← Leaderboards
David H Van Buren
Vanderbilt University
$0
Attributed
$0
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
NIH$0 · 1
By mechanism
M01$0 · 1
Top collaborators
No co-investigators on record.
Most similar at Vanderbilt University
Same institution · by research overlap
- Barney S Graham$269,836
- Nancy Joan Brown$32,445,188
- David Herlie Robertson$14,232,685
- Stephen N. Davis$16,024,395
- Grant R. Wilkinson$1,933,364
Others in their field
Top investigators on “Pharmacokinetics”
- Leonard Freedman · Leidos Biomedical Research, Inc.$237,100,725
- Constance Ann Benson · University Of California, San Diego$151,891,628
- Richard L Schilsky · University Of Chicago$114,474,127
- Ronald T Mitsuyasu · University Of California Los Angeles$105,970,100
- Wafaa M. El-Sadr · Columbia University Health Sciences$91,574,471
- Myron S Cohen · Family Health International$91,263,426
Research focus
PharmacokineticsClinical ResearchCyclosporinesKidney TransplantationArtificial ImmunosuppressionHuman SubjectHuman Therapy EvaluationDrug Screening /EvaluationOutcomes Research
Grant awards (5)
OLN 455 CYCLOSPORINE EXPOSURE OF STABLE RENAL TRANSPLANT PATIENT WITH SANDIMMUNE$0
M01 · FY2002 · RR
OLN 455 CYCLOSPORINE EXPOSURE OF STABLE RENAL TRANSPLANT PATIENT WITH SANDIMMUNE$0
M01 · FY2001 · RR
OLN 455 CYCLOSPORINE EXPOSURE OF STABLE RENAL TRANSPLANT PATIENT WITH SANDIMMUNE$0
M01 · FY2001 · RR
OLN 455 CYCLOSPORINE EXPOSURE OF STABLE RENAL TRANSPLANT PATIENT WITH SANDIMMUNE$0
M01 · FY2001 · RR
OLN 455 CYCLOSPORINE EXPOSURE OF STABLE RENAL TRANSPLANT PATIENT WITH SANDIMMUNE$0
M01 · FY2000 · RR